Bruce Wienberg - Extendicare VP Care
| EXETFDelisted Stock | USD 5.00 0.00 0.00% |
Insider
Bruce Wienberg is VP Care of Extendicare
| Phone | 905 470 4000 |
| Web | https://www.extendicare.com |
Extendicare Management Efficiency
The company has return on total asset (ROA) of 0.1102 % which means that it generated a profit of $0.1102 on every $100 spent on assets. This is way below average. Extendicare's management efficiency ratios could be used to measure how well Extendicare manages its routine affairs as well as how well it operates its assets and liabilities.Extendicare has accumulated 463.27 M in total debt with debt to equity ratio (D/E) of 2.85, implying the company greatly relies on financing operations through barrowing. Extendicare has a current ratio of 1.07, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Extendicare until it has trouble settling it off, either with new capital or with free cash flow. So, Extendicare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Extendicare sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Extendicare to invest in growth at high rates of return. When we think about Extendicare's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| FACHE MBA | Oncology Institute | 43 | |
| Robert Hollister | Sonida Senior Living | 64 | |
| Helen Giza | Fresenius SE Co | 55 | |
| Pete Hartley | Amedisys | N/A | |
| Andrew Mok | CareRx | N/A | |
| Doug Meagher | Ramsay Health Care | N/A | |
| Kelly Hibbins | Ramsay Health Care | N/A | |
| David Watson | Medical Facilities | 57 | |
| Karen VargaSinka | Cross Country Healthcare | N/A | |
| Jennifer Griffin | Amedisys | N/A | |
| Brandon CPA | Sonida Senior Living | 43 | |
| Sebastian Biedenkopf | Fresenius SE Co | 59 | |
| Kevin Blaylock | Medical Facilities | N/A | |
| Denise Bohnert | Amedisys | 46 | |
| Matthias Link | Fresenius SE Co | N/A | |
| John Nugent | Amedisys | N/A | |
| Tiffany Dutton | Sonida Senior Living | 43 | |
| Diona CPA | Oncology Institute | 44 | |
| Alison DeBlois | Nova Leap Health | N/A | |
| LLB BECON | Ramsay Health Care | N/A | |
| Gerald Purgay | Cross Country Healthcare | 62 | |
Management Performance
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 |
Extendicare Leadership Team
Elected by the shareholders, the Extendicare's board of directors comprises two types of representatives: Extendicare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Extendicare. The board's role is to monitor Extendicare's management team and ensure that shareholders' interests are well served. Extendicare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Extendicare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ali Mir, ParaMed VP | ||
| Lisa Pearson, VP Affairs | ||
| David Bacon, CFO, Senior Vice President | ||
| Matthew Morgan, Chief Officer | ||
| Leslie Sarauer, VP Officer | ||
| Bruce Wienberg, VP Care | ||
| John Toffoletto, Chief VP | ||
| Steve Paraskevopoulos, VP CTO | ||
| Elaine Everson, CFO and VP | ||
| MBA MD, Pres CEO | ||
| Jillian Fountain, Corporate Secretary |
Extendicare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Extendicare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0018 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 556.43 M | ||||
| Shares Outstanding | 83.94 M | ||||
| Shares Owned By Insiders | 13.15 % | ||||
| Shares Owned By Institutions | 17.61 % | ||||
| Price To Earning | 500.00 X | ||||
| Price To Book | 4.28 X |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Extendicare Pink Sheet
If you are still planning to invest in Extendicare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Extendicare's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |